Adoptive immunotherapy with interleukin-7

Details Adoptive immunotherapy with interleukin-7 Adoptive immunotherapy with interleukin-7

A - Human Necessities

61

K

A61K 35/14 (2006.01) A61K 35/18 (2006.01) A61K 38/20 (2006.01) A61K 39/00 (2006.01) A61P 31/12 (2006.01) A61P 35/00 (2006.01) C12N 5/02 (2006.01) C12N 5/08 (2006.01) C12N 5/06 (2006.01)

Patent

CA 2087525

There is disclosed an immunotherapy method for treating an individual with cancer or a viral infection comprising obtaining lymphoid cells previously exposed to a specific antigen, culturing the lymphoid cells ex vivo in a culture medium containing an effective amount of an IL-7 polypeptide or a functional derivative thereof to induce CTL activity in the lymphoid cells and administering the lymphoid cells having CTL activity for cells displaying the specific antigen to an individual.

Affiliated with

Also associated with

Rating

Adoptive immunotherapy with interleukin-7 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adoptive immunotherapy with interleukin-7, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adoptive immunotherapy with interleukin-7 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1863662